 The U.S. will pay vaccine maker Moderna $176 million to develop an mRNA pandemic flu vaccine. It could be used to treat bird flu in people, as cases in dairy cows have increased across the country. The Department of Health and Human Services today says it's funding the development of the vaccine, and it's based on the same mRNA technology that allowed the rapid development of the COVID-19 vaccine.